These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 20713668)
1. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Kohno S; Kida H; Mizuguchi M; Shimada J; Antimicrob Agents Chemother; 2010 Nov; 54(11):4568-74. PubMed ID: 20713668 [TBL] [Abstract][Full Text] [Related]
2. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J; Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298 [TBL] [Abstract][Full Text] [Related]
3. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials. Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121 [TBL] [Abstract][Full Text] [Related]
4. Peramivir: A Review in Uncomplicated Influenza. Scott LJ Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis. Lee J; Park JH; Jwa H; Kim YH Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991 [TBL] [Abstract][Full Text] [Related]
6. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09. Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265 [TBL] [Abstract][Full Text] [Related]
7. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Kohno S; Kida H; Mizuguchi M; Hirotsu N; Ishida T; Kadota J; Shimada J; Antimicrob Agents Chemother; 2011 Jun; 55(6):2803-12. PubMed ID: 21464252 [TBL] [Abstract][Full Text] [Related]
9. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques. Kitano M; Itoh Y; Kodama M; Ishigaki H; Nakayama M; Ishida H; Baba K; Noda T; Sato K; Nihashi Y; Kanazu T; Yoshida R; Torii R; Sato A; Ogasawara K Antimicrob Agents Chemother; 2011 Nov; 55(11):4961-70. PubMed ID: 21844317 [TBL] [Abstract][Full Text] [Related]
11. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors. Komeda T; Ishii S; Itoh Y; Sanekata M; Yoshikawa T; Shimada J J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Barroso L; Treanor J; Gubareva L; Hayden FG Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of peramivir for influenza treatment. Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation. Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921 [TBL] [Abstract][Full Text] [Related]
17. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza. Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636 [TBL] [Abstract][Full Text] [Related]
18. Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data. Choi WS; Ryu SY; Lee J; Hong SB; Eom JS; Shin J; Park KH; Ohk T; Chung JW; Chung DR; Kim DK; Lee SR; Kim PY; Kim SW; Noh JY; Song JY; Cheong HJ; Kim WJ J Korean Med Sci; 2018 Aug; 33(32):e212. PubMed ID: 30079005 [TBL] [Abstract][Full Text] [Related]
19. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan. Hirotsu N; Saisho Y; Hasegawa T; Shishido T Expert Rev Anti Infect Ther; 2018 Feb; 16(2):173-182. PubMed ID: 29284320 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W; Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]